Deadline for NMRA Investor: Neumora Therapeutics, Inc. Investors with significant losses have the opportunity to conduct a lawsuit for class action

Your email address will not be published. Required fields are marked *

Comment *

Name *

Email *

Website

Save my name, email, and website in this browser for the next time I comment.